What is ESSA Pharma Inc.'s current stock price?

ESSA Pharma Inc. (EPIX) currently trades at USD 0.2012. Track real-time price changes and historical performance on AllInvestView.

What sector is ESSA Pharma Inc. in?

ESSA Pharma Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

ESSA Pharma Inc. EPIX · Stock Open ESSA Pharma Inc. in new tab

0.2012 USD

Add to portfolio

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for ESSA Pharma Inc. (EPIX)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ESSA Pharma Inc. Analysis (EPIX)

Canada Health Care Official Website Stock

Is ESSA Pharma Inc. a good investment? ESSA Pharma Inc. (EPIX) is currently trading at 0.2012 USD.

Investor FAQ

Does ESSA Pharma Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is ESSA Pharma Inc.?

ESSA Pharma Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Exchange Ticker

NMS (United States) EPIX

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
April 25, 2018	0.050000

ESSA Pharma Inc. EPIX · Stock Open ESSA Pharma Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

ESSA Pharma Inc. Analysis (EPIX)

Investor FAQ

Company Profile

Fundamentals

Under Construction

ESSA Pharma Inc. EPIX · Stock Open ESSA Pharma Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

ESSA Pharma Inc. Analysis (EPIX)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications